请输入或粘贴题目内容
搜题
如搜索结果不匹配，请联系老师获取答案
题目内容
（请给出正确答案）
A.会计师事务所及其人员遵守法律法规、职业道德规范以及审计准则的规定
B.会计师事务所及其人员遵守审计、审阅准则、其他鉴证业务准则和相关服务准则的规定
C.对于特定业务实施项目质量控制复核，减轻项目负责人的责任
D.会计师事务所和项目负责人根据具体情况出具恰当的报告
答案
更多“根据材料，回答 35～37 题： A注册会计师为甲公司2×10年度财务报表审计的项目负责人，关于质量控”相关的问题
第2题
A.名称权
B.名誉权
C.荣誉权
D.信誉权
第3题
A.光面内质网
B.高尔基体
C.溶酶体
D.线粒体
第4题
根据下列材料，回答 1～6 题：
第 1 题 该项目的建设对环境影响的特殊性主要表现在哪些方面？
第5题
根据下面材料，回答第 31～35 题：
In 2010. a federal judge shook America's biotech industry to its core. Companies had won patents for isolated DNA for decades-by 2005 some 20% of human genes were parented. But in March 2010 a judge ruled that genes were unpatentable. Executives were violently agitated. The Biotechnology Industry Organisation (BIO), a trade group, assured members that this was just a “preliminary step” in a longer battle.
On July 29th they were relieved, at least temporarily. A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer. The chief executive of Myriad, a company in Utah, said the ruling was a blessing to firms and patients alike.
But as companies continue their attempts at personalised medicine, the courts will remain rather busy. The Myriad case itself is probably not over. Critics make three main arguments against gene patents: a gene is a product of nature, so it may not be patented; gene patents suppress innovation rather than reward it; and patents' monopolies restrict access to genetic tests such as Myriad's. A growing number seem to agree. Last year a federal task-force urged reform. for patents related to genetic tests. In October the Department of Justice filed a brief in the Myriad case, arguing that an isolated DNA molecule “is no less a product of nature... than are cotton fibres that have been separated from cotton seeds.”
Despite the appeals court's decision, big questions remain unanswered. For example, it is unclear whether the sequencing of a whole genome violates the patents of individual genes within it. The case may yet reach the Supreme Court.
AS the industry advances, however, other suits may have an even greater impact. Companies are unlikely to file many more patents for human DNA molecules - most are already patented or in the public domain .firms are now studying how genes interact, looking for correlations that might be used to determine the causes of disease or predict a drug’s efficacy. Companies are eager to win patents for ‘connecting the dots’, explains Hans Sauer, a lawyer for the BIO.
Their success may be determined by a suit related to this issue, brought by the Mayo Clinic, which the Supreme Court will hear in its next term. The BIO recently held a convention which included sessions to coach lawyers on the shifting landscape for patents. Each meeting was packed.
第 31 题 It can be learned from paragraph I that the biotech companies would like______
A．their executives to be active
B．judges to rule out gene patenting
C．genes to be patentable
D．the BIO to issue a warning
第6题
根据下列材料回答问题。
第 121 题 2000年至2006年黄金储备量下降幅度超过11%的国家有多少个？（）
第8题
根据以下材料回答 36～40 ：
第 36 题 Citibank used to look for executives for its operations ___________.
B) in Shanghai
C) in the U.K.
D) in some cities
第9题
A.大气降水量增加
B.地表径流量增加
C.下渗水量增加
D.蒸腾作用增加
第10题
A.卫生注册登记（备案）
B.FDA注册
C.蔬菜种植基地备案
D.国外收货人备案登记
